Abbott sees the delivery system as a differentiator for its TAVR, and this is a great strategic choice on the part of Abbott. They've made the decision to improve all aspects of their Portico TAVR device, not just the valve itself.
TAVR is a bare knuckles fighting market. But, if you make the device easier to use and place, it can grab a critical share of market for your product.
Santosh Prabhu (Divisional VP, Product Development of Abbott Structural Heart) outlined 5 ways they improved the delivery system for the Portico device:
| Portico Device Delivery Improvement | Unmet Need | |
|---|---|---|
| 1. | Calculated use of hydrophilic coatings | Address vasculature that is tough to navigate |
| 2. | Lower profile | Improves deliverability |
| 3. | Integrate the sheath | No need for a sheath that adds to the profile |
| 4. | Stability layer | Precise placement of the valve |
| 5. | Improved benchtop testing | Reduced need for clinical studies and delays |
The Medi-Vantage team can help you and your product development team uncover these unmet needs, so that engineers can focus on engineering the device.
You can see the full article at:
Let’s connect – mshepherd@medi-vantage.com
CONTACT US
LOOKING FOR A PARTNER WITH KEY INSIGHTS FROM CLINICIANS & HOSPITAL ADMINISTRATORS AND HOSPITAL CFOS?
OUR LAST THREE PROJECTS WERE:
What price premium can be charged for an upgraded legacy product in a commodity space?
Medtech price sensitivity analysis - hospital administrators and CFOs
M&A due diligence analysis: pricing for a new disruptive product